ArticleInvestigational new drugs2008

A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.

Wendy Stock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.